InvestorsHub Logo
icon url

learningcurve2020

05/12/21 8:25 AM

#376362 RE: anders2211 #376359

Not necessarily. I think shareholders end up with the Bavituximab / Avid story. But it took the removal of old management, of course, to see any common shareholders gain from Avid manufacturing. But then did it fly! Powers has it all set up quite differently then Avid so we'll see.